Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) Enterprise Value (2024 - 2025)

Caris Life Sciences has reported Enterprise Value over the past 2 years, most recently at -$799.3 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$799.3 million for Q4 2025, down 1081.68% from a year ago — trailing twelve months through Dec 2025 was -$799.3 million (down 1081.68% YoY), and the annual figure for FY2025 was -$799.3 million, down 1081.68%.
  • Enterprise Value for Q4 2025 was -$799.3 million at Caris Life Sciences, down from -$756.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for CAI hit a ceiling of -$67.6 million in Q4 2024 and a floor of -$799.3 million in Q4 2025.